DADayawa Da Agoons

Dayawa Da Agoons

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Dayawa Da Agoons has a total of 23 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Apolipoprotein B and Glycemic Indices in Normoglycemic Adults: Analysis of the National Health and Nutrition Examination Survey, 2007-2016

    by Dayawa D. Agoons, Batakeh B. Agoons

    Introduction Insulin resistance (IR) and pancreatic B-cell dysfunction are fundamental disorders in the pathogenesis of type 2 diabetes. Recent evidence suggests that apolipoprotein B (Apo-B) may be related to the onset of type 2 diabetes. However, the mechanism explaining this association is unclear. Methods We analyzed data from 4888 normoglycemic adults pooled from the 2007-2016 National Health and Nutrition Examination Survey (NHANES). Participants were categorized by tertiles of Apo-B, and the main outcome measures were IR and pancreatic β-cell function ascertained by homeostasis model assessment for insulin resistance (HOMA-IR) and homeostasis model assessment for beta cell function (HOMA-β), respectively. Poisson and linear regressions were used to generate prevalence ratios (PRs) and β coefficients for IR and β-cell function, respectively. Results Among 4888 participants, the mean Apo-B was 0.85 ± 0.2 g/L, and 532 (10.8%) had IR. After adjusting for demographic variables, the PRs (95% CI) for IR comparing higher tertiles (T2 and T3) with the lowest tertile (T1) of Apo-B were 1.49 (1.19-1.88) and 1.92 (1.54-2.39), respectively. There was a significant increase in log HOMA-β for T2 and T3 compared to T1 of Apo-B, after adjusting for demographic variables (β 0.05 (95% CI: 0.01-0.09) and β 0.15 (95% CI: 0.11-0.19), respectively). Additional adjustment for lifestyle and metabolic variables did not change the significance of these findings. There was a significant graded increase in log HOMA-IR and HOMA-β from T2 to T3 (P for trend <0.001). Conclusion Apo-B was associated with increased IR and pancreatic β-cell function in normoglycemic adults independently of traditional risk factors for diabetes. These findings suggest that Apo-B may be associated with the development of glycemic dysregulation.


  • Open Access

    Author's response

    by Dayawa D. Agoons, Batakeh B. Agoons, Kelechi E. Emmanuel, Firdausi A. Matawalle, Jessica M. Cunningham

  • Open Access

    Correlates of cardiorespiratory fitness among overweight or obese individuals with type 2 diabetes

    by Arnaud D Kaze, Dayawa Da Agoons, Prasanna Santhanam, Sebhat Erqou, Rexford S Ahima, Justin B Echouffo-Tcheugui

    Introduction Mechanistic studies suggest that type 2 diabetes is independently associated with low cardiorespiratory fitness (CRF). Little is known about the CRF profile in type 2 diabetes; we assessed the correlates of low CRF among overweight/obese adults with type 2 diabetes. Research design and methods A total of 4215 participants with type 2 diabetes and without cardiovascular disease underwent maximal exercise testing in the Look AHEAD (Action for Health in Diabetes) study. Low CRF was defined based on the Aerobics Center Longitudinal Study reference standards. Calorie intake and physical activity were assessed using questionnaires. Body fat composition was assessed using dual-energy X-ray absorptiometry. Results Waist circumference, systolic blood pressure, glycemic measures, whole body fat, caloric intake, and fat-free mass were inversely associated with fitness across sex (all pConclusions Low CRF was associated with increased odds of cardiometabolic correlates in a large cohort of adults with type 2 diabetes.


  • Open Access

    Effect of Serum Ferritin on the Association Between Coffee Intake and Hyperuricemia Among American Women: The National Health and Nutrition Examination Survey

    by Dayawa D. Agoons, Batakeh B. Agoons, Arnaud D. Kaze, Saketram Komanduri

    Background Accruing evidence suggests an inverse relationship between coffee intake and serum uric acid. The mechanism(s) explaining this inverse relationship remains elusive. The aim of this study was to assess if the association between coffee intake and hyperuricemia is mediated via serum ferritin in women. Methods We pooled data from the 2003 to 2006 National Health and Nutrition Examination Survey (NHANES). We included women with complete information on all key variables. Coffee intake was classified as none, = 4 cups/day. Hyperuricemia was defined as serum uric acid >5.7 mg/dL. We assessed the association between coffee intake and hyperuricemia using logistic regression. Path analysis was used to examine whether serum ferritin mediated the effect of coffee on hyperuricemia. Results Among 2,139 women (mean age: 31.2 years [SD: 9.2]), mean serum uric acid was 4.4 mg/dL (SD: 1.0), and 227 (10.6%) had hyperuricemia. In multivariate logistic regression models, intake of >= 4 cups/day of coffee was associated with lower odds of hyperuricemia (OR 0.28 [95% CI: 0.09, 091], P=0.035). The total direct and indirect effect of coffee on hyperuricemia via serum ferritin was -0.16, P=0.009 and -8.1 x 10(-3), P=0.204, respectively. Conclusion Among women, moderate coffee consumption was inversely related to hyperuricemia by direct effect, rather than indirectly through the effects of serum ferritin. These findings suggest that serum ferritin does not mediate the inverse association between coffee and hyperuricemia in women.


  • Open Access

    Association between electronic cigarette use and fragility fractures among US adults

    by Dayawa D. Agoons, Batakeh B. Agoons, Kelechi E. Emmanuel, Firdausi A. Matawalle, Jessica M. Cunningham


  • Open Access

    Effect of Topical Capsaicin on Painful Sensory Peripheral Neuropathy in Patients with Type 2 Diabetes: A Double-Blind Placebo-Controlled Randomised Clinical Trial

    by Batakeh Ba Agoons, Mesmin Dehayem Yefou, Jean-Claude Katte, Martine Claude Etoa Etoga, Dayawa D. Agoons, Faustin Yepnjio, Anne Boli, Yves Wasnyo, Eugene Sobngwi, Jean-Claude Mbanya

    The aim of this study was to evaluate the efficacy of capsaicin in inducing significant pain relief in a population of sub-Saharan African type 2 diabetic patients with painful peripheral neuropathy. This was a prospective double-blind placebo-controlled randomised clinical trial. A single tertiary-level hospital diabetes center in Yaounde, Cameroon. Twenty-two participants with type 2 diabetes mellitus, presenting with painful diabetic neuropathy, aged 18 years and above. Participants were equally randomised to capsaicin or placebo. Each drug was to be applied on the lower limbs thrice daily. Follow-up was done every two weeks for eight weeks. Reduction in the median pain score from baseline, as assessed by the Visual Analogue Scale. Twenty-two participants aged 57.5 (50-60) years with a median pain intensity of 6.8 units in the capsaicin group and 5.8 units in the placebo group were included; at inclusion, there was no significant difference in the two groups (p=0.29). After two weeks, the value of pain intensity was 3.3 [2.5-4.0] vs 5.0 [4.0-7.4] (p=0.003); at week four, 3.0 [2.5-3.3] vs 5.0 [4.2-5.5] (p=0,02); at week six, 3.3 [2.5-4.0] vs 4.8 [4.0-6.0] (p=0.03); and at week eight, 6.6 [6.0-7.0] vs 5.2 [5.0-6.0] (p=0.54) for capsaicin and placebo respectively. This study, carried out due to a paucity of information on the effect of capsaicin and painful diabetic neuropathy in sub-Saharan African diabetes patients, shows that capsaicin significantly reduces neuropathic pain with worsening after eight weeks of use. Pan Africa Trial Registry: PACTR202003714748946.